Menu
Not yet recruiting NCT06683963

AI-Assisted TelerehabiLitAtion System (ATLAS) for Post-discharge Continuation of Rehabilitative Care

No phase Interventional Rehabilitation Deconditioning

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Rebee.
Who it may be relevant to
Registry conditions: Rehabilitation, Deconditioning. Basic parameters: 60 years — 99 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

The study team proposes ATLAS (AI-Assisted TelerehabiLitAtion System) a two-part solution. The first-Rebee AI-assisted telerehabilitation device-assists in inpatient rehabilitation, and allows patients to continue with their physical rehabilitation when discharged and waiting for Day Rehabilitation Centre (DRC). The second-a structured programme to train and familiarise patients and caregivers to Rebee over patients' Community Hospital (CH) inpatient rehabilitation stay-adopts an evidence-based approach to increase uptake and adherence to Rebee.

Interventions

  • Device Rebee
    Tablet device with accompanying sensor device. Tablet device is preloaded with exercises, to be taught to patients during their hospital stay, and to be continued post-discharge

Primary outcome measures

  • Change in Modified Barthel Index scores from baseline to 4, 8, and 12 weeks [Time frame: from recruitment (week 0) till end of study at 12 weeks]
Secondary outcome measures (6)
  • Change in Quality of Life scores from baseline to 4, 8, and 12 weeks [Time frame: from recruitment (week 0) till end of study at 12 weeks]
  • Change in Patient Activation Level from baseline to 4, 8, and 12 weeks [Time frame: from recruitment (week 0) till end of study at 12 weeks]
  • Readmission rates to hospital within 30 days of discharge [Time frame: within 30 days from discharge date]
  • Change in Joint range of motion from baseline to 4, 8, and 12 weeks [Time frame: from recruitment (week 0) till end of study at 12 weeks]
  • Length of Stay in Community Hospital reported in days [Time frame: From recruitment (week 0) till end of study at 12 weeks]
  • Change in STS (sit to stand) score from baseline to 4, 8, and 12 weeks [Time frame: from recruitment (week 0) till end of study at 12 weeks]

Eligibility criteria

Inclusion criteria

  • Rehabilitation Diagnostic Group (RDG): Total Knee Replacement / Deconditioning
  • Age 60 and above
  • Speak English/Mandarin
  • Able to follow instructions, no cognitive impairment
  • No MDRO (MultiDrug Resistant Organism)
  • Suitable and able to wear motion sensor on upper and lower limbs
  • Suitable and able to engage in Rebee exercises

Exclusion criteria

  • Not under RDG: Total Knee Replacement / Deconditioning
  • Below 60 years old
  • Unable to speak English/Mandarin
  • Cognitive impaired, unable to follow instructions
  • Has MDRO
  • Not suitable to wear motion sensor on upper and lower limbs
  • Refusal to participate / give informed consent

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Treatment

Study locations

Center list to be confirmed — check the primary protocol.

Publications

  • Tan CYM, Seah XY, Seah SSY, Loh XH, Chua WHP, Xia OJ, D/O Chandran C, Hosain H, Qiu W, Chong K, Tai BC, Low LL. Implementation and Evaluation of an AI-Assisted Telerehabilitation System for Postdischarge Continuation of Rehabilitative Care: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2026 Aug 5;15:e78400. doi: 10.2196/78400. PMID 42555956

Identifiers

NCT: NCT06683963 · 20242246

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗